Client News

AiCuris and Lysando join forces in the fight against antimicrobial resistance

Biom’up issues a new tranche of EUR 5 million from the credit line granted by Athyrium

MorphoSys and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibitors of CD47-SIRP alpha Signaling in Immuno-Oncology

adl bionatur solutions enters into an initial EUR 13 million strategic alliance with japanese pharma company

Sterna biologicals strengthens management team to progress towards phase IIb development

CENTOGENE Reveals Growth of Rare Hereditary Disease Knowledge Base

Newron Receives First Tranche from Financing Agreement with European Investment Bank (EIB)

CENTOGENE Launches PICOPglobal: Two Year Global Study on Colon- and Pancreas-Carcinoma

Results of NOXXON annual general shareholders meeting

Newron Pharmaceuticals now also listed on the primary market of the Düsseldorf Stock Exchange and on XETRA